Detalhe da pesquisa
1.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.
Lancet
; 395(10239): 1763-1770, 2020 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32442528
2.
Risk Factors for New Neurologic Diagnoses in Hospitalized Patients With COVID-19: A Case-Control Study in New York City.
Neurol Clin Pract
; 12(4): e66-e74, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36382116
3.
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19.
J Clin Invest
; 131(13)2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33974559
4.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.
medRxiv
; 2020 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32511638
5.
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Trials
; 21(1): 927, 2020 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203476
6.
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Trials
; 21(1): 499, 2020 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513308
7.
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Trials
; 21(1): 536, 2020 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32546220
8.
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19
Artigo
em Inglês
| Arca: Repositório institucional da Fiocruz | ID: arc-48429